Skip to content

XENEXENON PHARMACEUTICALS INC

CUSIP 98420N105 · common stock

2 tracked investors held XENON PHARMACEUTICALS INC (XENE) at the end of Q3 2026, worth $57M in total. The largest holder was Adar1 Capital Management, with 1.8% of its portfolio. 3 investors sold out this quarter, including Stanley Druckenmiller.

Holders · Q3 2026
2
New holders
0
Value held
$57M
Quarter-end price (est.)
$37.19

Investors holding XENE · Q3 2026

InvestorWeightSharesValueChange
Adar1 Capital Management
ADAR1 Capital Management, LLC
1.84%1,162,029$43.2MADD+597.7%
Julian Baker
Baker Bros. Advisors LP
0.07%370,208$13.8MHOLD

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Stanley Druckenmiller0.28%238,600$14.4MEXIT
Chuck Royce0.03%65,032$3.9MEXIT
Ron Baron0.00%25,000$1.5MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026203$57M$37.19
Q2 2026510$52.2M$60.36
Q1 2026411$50.2M$58.15
Q4 2025400$36.1M$44.82